MedsChat.com

The People's Medicine Community ®
Drug Index: 

Aptivus

Active Ingredient(s): Tipranavir
FDA Approved: June 22, 2005
Pharm Company: BOEHRINGER INGELHEIM
Category: HIV / AIDS

Welcome to the Aptivus information hub. Scroll down to read supplemental details and discuss this drug.


Aptivus Overview

Tipranavir, or tipranavir disodium, is a nonpeptidic protease inhibitor (PI) manufactured by Boehringer-Ingelheim under the trade name Aptivus. It is administered with ritonavir in combination therapy to treat HIV infection and is given as two 250mg capsules together with 200mg of ritonavir twice daily. Tipranavir has the ability to inhibit the replication of viruses that are resistant to other protease inhibitors and it recommended for patients who are resistant to other treatments. Resistan...

Read more Aptivus Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: http://en.wikipedia.org/wiki/Tipranavir

Recent Aptivus Forums: RSS Feed

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tipranavir
  • Capsule: 250mg
  • Solution: 100mg/ml, 250mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Tipranavir or a similar ingredient: (1 result)